Literature DB >> 8215090

Saliva testing for drugs of abuse.

E J Cone1.   

Abstract

Saliva testing for drugs of abuse can provide both qualitative and quantitative information on the drug status of an individual undergoing testing. Self-administration by the oral, intranasal, and smoking routes often produces "shallow depots" of drug that contaminate the oral cavity. This depot produces elevated drug concentrations that can be detected for several hours. Thereafter, saliva drug concentrations generally reflect the free fraction of drug in blood. Also, many drugs are weak bases and saliva concentrations may be highly dependent upon pH conditions. These factors lead to highly variable S/P ratios for many of the drugs of abuse. Table 3 provides a compilation of experimental and theoretical S/P (total) ratios determined for drugs of abuse. Estimations of the theoretical S/P (total) ratios for acidic and basic drugs were based on the Henderson-Hasselbalch equation. Saliva pH was assumed to be 6.8 unless reported otherwise by the investigators. Generally, there was a high correlation of saliva drug concentrations with plasma, especially when oral contamination was eliminated. Assay methodology varied considerably, indicating that saliva assays could be readily developed from existing methodology. There are many potential applications for saliva testing for drugs of abuse. Table 4 lists several general areas in which information from saliva testing would be useful. Clearly, saliva drug tests can reveal the presence of a pharmacologically active drug in an individual at the time of testing. Significant correlations have been found between saliva concentrations of drugs of abuse and behavioral and physiological effects. Results indicate that saliva testing can provide valuable information in diagnostics, treatment, and forensic investigations of individuals suspected of drug abuse. It is expected that saliva testing for drugs of abuse will develop over the next decade into a mature science with substantial new applications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215090     DOI: 10.1111/j.1749-6632.1993.tb18346.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

Review 1.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

2.  Direct analysis of liquid samples by desorption electrospray ionization-mass spectrometry (DESI-MS).

Authors:  Zhixin Miao; Hao Chen
Journal:  J Am Soc Mass Spectrom       Date:  2008-09-30       Impact factor: 3.109

Review 3.  Drug monitoring in nonconventional biological fluids and matrices.

Authors:  S Pichini; I Altieri; P Zuccaro; R Pacifici
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

4.  MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.

Authors:  Allan J Barnes; Karl B Scheidweiler; Erin A Kolbrich-Spargo; David A Gorelick; Robert S Goodwin; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-10       Impact factor: 3.681

5.  Drug testing in oral fluid.

Authors:  Olaf H Drummer
Journal:  Clin Biochem Rev       Date:  2006-08

6.  Optimum methadone compliance testing: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-12-01

7.  Salt tolerance of desorption electrospray ionization (DESI).

Authors:  Ayanna U Jackson; Nari Talaty; R Graham Cooks; Gary J Van Berkel
Journal:  J Am Soc Mass Spectrom       Date:  2007-10-02       Impact factor: 3.109

Review 8.  Saliva: an emerging biofluid for early detection of diseases.

Authors:  Yu-Hsiang Lee; David T Wong
Journal:  Am J Dent       Date:  2009-08       Impact factor: 1.522

9.  Measuring nicotine intake among highly-dependent adolescent smokers: comparability of saliva and plasma cotinine concentrations.

Authors:  Craig S Parzynski; Maria Jaszyna-Gasior; Frederick H Franken; Eric T Moolchan
Journal:  Pharmacol Biochem Behav       Date:  2007-12-08       Impact factor: 3.533

10.  Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients.

Authors:  Courtney D Nordeck; Jan Gryczynski; Kevin E O'Grady; Kathryn Polak; Dace S Svikis; Jennifer McNeely; Li-Tzy Wu; Robert P Schwartz
Journal:  Drug Alcohol Depend       Date:  2020-02-22       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.